Ortho Clinical Diagnostics to Host Transfusion Medicine Summit in China

Ortho Clinical Diagnostics to Host Transfusion Medicine Summit in China

Mar 16, 2018

Industry Launch Meeting to Unveil ORTHO VISION® Platform of Immunohematology Analyzers

RARITAN, N.J. and SHANGHAI – Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, will host its second annual Transfusion Medicine Summit in Xi’an, China, on March 17, 2018.  At the event, leading experts in transfusion medicine will present on key topics to an audience of more than 100 laboratory and medical professionals.  Ortho will also launch its ORTHO VISION® Platform, which matches blood for use in transfusion, in China at the event. 

“As a global leader in immunohematology, Ortho is committed to developing automated, scalable, integrated products to help the hospitals, blood banks and labs we serve manage their workloads efficiently and effectively,” said Michael Lin, head of Ortho Greater China.  “We look forward to bringing together some of China’s most forward-thinking experts to discuss new and innovative approaches to improve transfusion safety.”

At the Transfusion Medicine Summit, the major topics will include: systematic quality control for transfusions; transfusion management in pregnancy; speed and reach of blood transfusion testing; existing challenges in transfusion medicine in China; achieving improved pre-transfusion testing through process control; and a new view of automated testing solutions. 

At the event, Ortho will also formally launch its ORTHO VISION Platform, which helps blood banks keep pace with growing industry pressure to increase productivity while remaining operationally efficient, by improving workflow and standardizing systems and processes.  It also automates complex immunohematology testing, such as serial dilutions for titration studies, reflex tests and selected cell antibody identification. The ORTHO VISION Platform is comprised of the ORTHO VISION Max, which was developed for mid- to high-volume labs, and the ORTHO VISION, which was developed for low- to mid-volume labs. 

The ORTHO VISION platform has received a string of accolades for its ability to innovate in transfusion medicine.  Earlier this year, the ORTHO VISION Platform was recognized with an Edison™ Award for Innovation.  It also received a 2016 Innovation Award by members of Premier, Inc., a health care improvement company that unites an alliance of approximately 3,600 U.S. hospitals and 120,000 other providers around the goal of transforming health care, and a Global Business Excellence 2017 Award for Product Innovation.

About Ortho Clinical Diagnostics
Ortho Clinical Diagnostics is a global leader of in vitro diagnostics serving the global clinical laboratory and immunohematology communities. Across hospitals, hospital networks, blood banks, and labs in more than 125 countries and territories, Ortho’s high-quality products and services enable health care professionals to make better-informed treatment decisions. For the immunohematology community, Ortho’s blood typing products help ensure every patient receives blood that is safe, the right type and the right unit. Ortho brings sophisticated testing technologies, automation, information management and interpretation tools to clinical laboratories around the world, helping them run more efficiently and effectively, and improve patient care. Ortho’s purpose is to improve and save lives with diagnostics, and it does that by reimagining what’s possible. This is what has defined Ortho for more than 75 years, and it’s what drives Ortho forward. For more information, visit www.orthoclinicaldiagnostics.com.

© Ortho Clinical Diagnostics 2018

Press Contact:
Jane Ward
Ortho Clinical Diagnostics


© Ortho Clinical Diagnostics 2019. Ortho Clinical Diagnostics, publishes this site and is solely responsible for its content. The availability of the products is subject to compliance with the regulatory requirements of each market.